The University of Iowa Hospitals and Clinics — Iowa City, Iowa

The University of Iowa Hospitals and Clinics is a clinical research site located in Iowa City, Iowa, United States 52242.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Iowa Hospitals and Clinics has participated in 18 clinical trials with 2 currently active.

Therapeutic areas: Alpha 1-Antitrypsin Deficiency, Cystic Fibrosis, Alpha1-Antitrypsin Deficiency.

Sponsors: Vertex Pharmaceuticals Incorporated, MediWound Ltd, University of Iowa.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Iowa City

Browse all research sites in Iowa · View every site in Iowa City

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Iowa Hospitals and Clinics?

The University of Iowa Hospitals and Clinics has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Iowa Hospitals and Clinics conducted?

The University of Iowa Hospitals and Clinics has 18 clinical trials on record, with 2 currently active. Their work covers Alpha 1-Antitrypsin Deficiency, Cystic Fibrosis, Alpha1-Antitrypsin Deficiency.

Is The University of Iowa Hospitals and Clinics accredited by Crixeo Clinical Trials?

The University of Iowa Hospitals and Clinics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Iowa Hospitals and Clinics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.